S.D. Admin. R. 44:73:04:12

Current through Register Vol. 51, page 67, December 16, 2024

Section 44:73:04:12 - Tuberculin screening and testing requirements

Each facility shall develop criteria to screen healthcare personnel and residents for Mycobacterium tuberculosis (TB) based on the Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019. Each facility shall establish policies and procedures for conducting TB risk assessments that include responsibility, surveillance, and containment. The frequency of repeat screenings depend upon annual risk assessments conducted by the facility. Any resident identified as asymptomatic upon admission with an anticipated stay of thirty days or less is not required to have a tuberculin skin test or a TB blood assay test.

Tuberculin screening requirements for healthcare personnel or residents are as follows:

(1) Each new healthcare personnel or resident shall receive an initial individual TB risk assessment and the two-step method of tuberculin skin test or a TB blood assay test to establish a baseline within twenty-one days of employment or admission to a facility. The qualified personnel must record the assessment and the test in the employee's record or the resident's medical record. Any two documented tuberculin skin tests completed within a twelve-month period prior to the date of admission or employment is considered a two-step test. A TB blood assay test completed within a twelve-month period prior to the date of admission or employment is an adequate baseline test. Skin testing or TB blood assay tests are not necessary if a new healthcare personnel or resident transfers from one licensed healthcare facility to another licensed healthcare facility within the state if the facility received documentation from the transferring healthcare facility, healthcare personnel, or resident, of the last skin testing having been completed within the prior twelve months. Skin testing or a TB blood assay test is not necessary if documentation is provided by the transferring healthcare facility, healthcare personnel, or resident, of a previous positive reaction to either test. Any new healthcare personnel or resident who has a newly recognized positive reaction to the skin test or TB blood assay test must have a medical evaluation and a chest X-ray to determine the presence or absence of the active disease;

(2) A new healthcare personnel or resident who provides documentation of a positive reaction to the tuberculin skin test or TB blood assay test must have a medical evaluation and chest X-ray to determine the presence or absence of the active disease;

(3) Each healthcare personnel or resident with a history of a positive reaction to the tuberculin skin test or blood assay must be evaluated annually by a physician, physician assistant, nurse practitioner, clinical nurse specialist, or nurse, and a record must be maintained of the presence or absence of symptoms of TB. If this evaluation results in suspicion of active tuberculosis, the person must be referred for further medical evaluation to confirm the presence or absence of tuberculosis; and

(4) Each healthcare personnel or resident identified at increased risk for TB because of an occupational risk or current or planned immunosuppression shall receive an annual TB risk screening.

S.D. Admin. R. 44:73:04:12

42 SDR 51, effective 10/13/2015; 51 SDR 053, effective 11/11/2024

General Authority: SDCL 34-12-13(1)(5)(14), 34-22-9.

Law Implemented: SDCL 34-12-13.

Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, May 17, 2019. Copies may be obtained at no cost at https://www.cdc.gov/mmwr/volumes/68/wr/mm6819a3.htm.